In agreement with results from human cancer cells, the depletion of MNX1 via CRISPR/Cas9 also reduced PD‐L1 expression in 4T1 mouse breast cancer cells and mEC25 mouse ESCC cells (Figure 2h–j). This evidence concerns the gene CD274 and breast carcinoma.